☰

Ronald J. Levy, Ph.D. - Publications

Affiliations: 
2004 Louisiana State University, Baton Rouge, LA, United States 
Area:
Agronomy Agriculture, Agricultural Economics
Tree Info Similar researchers PubMed Report error

30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Shree T, Haebe SE, Czerwinski DK, Eckhert E, Day G, Sathe A, Grimes SM, Frank MJ, Maeda L, Alizadeh AA, Advani RH, Hoppe RT, Long SR, Martin BA, Ozawa MG, ... ... Levy R, et al. A clinical trial of therapeutic vaccination in lymphoma with serial tumor sampling and single cell analysis. Blood Advances. PMID 37939259 DOI: 10.1182/bloodadvances.2023011589  0.341
2022 Sagiv-Barfi I, Czerwinski DK, Shree T, Lohmeyer JJK, Levy R. Intratumoral immunotherapy relies on B and T cell collaboration. Science Immunology. 7: eabn5859. PMID 35622903 DOI: 10.1126/sciimmunol.abn5859  0.308
2021 Miller CL, Sagiv-Barfi I, Neuhöfer P, Czerwinski DK, Artandi SE, Bertozzi CR, Levy R, Cochran JR. Systemic delivery of a targeted synthetic immunostimulant transforms the immune landscape for effective tumor regression. Cell Chemical Biology. PMID 34774126 DOI: 10.1016/j.chembiol.2021.10.012  0.319
2021 Haebe SE, Shree T, Sathe A, Day G, Czerwinski DK, Grimes S, Lee H, Binkley MS, Long SR, Martin BA, Ji HP, Levy R. Single Cell Analysis Can Define Distinct Evolution of Tumor Sites in Follicular Lymphoma. Blood. PMID 33728464 DOI: 10.1182/blood.2020009855  0.305
2020 Frank MJ, Khodadoust MS, Czerwinski DK, Haabeth OAW, Chu MP, Miklos DB, Advani RH, Alizadeh AA, Gupta NK, Maeda LS, Reddy SA, Laport GG, Meyer EH, Negrin RS, Rezvani AR, ... ... Levy R, et al. Autologous tumor cell vaccine induces antitumor T cell immune responses in patients with mantle cell lymphoma: A phase I/II trial. The Journal of Experimental Medicine. 217. PMID 32558897 DOI: 10.1084/Jem.20191712  0.315
2018 Andor N, Simonds EF, Czerwinski DK, Chen J, Grimes SM, Wood-Bouwens C, Zheng GXY, Kubit MA, Greer S, Weiss WA, Levy R, Ji HP. Single-cell RNA-Seq of lymphoma cancers reveals malignant B cell types and co-expression of T cell immune checkpoints. Blood. PMID 30591526 DOI: 10.1182/Blood-2018-08-862292  0.337
2018 Sallets A, Robinson S, Kardosh A, Levy R. Enhancing immunotherapy of STING agonist for lymphoma in preclinical models. Blood Advances. 2: 2230-2241. PMID 30194137 DOI: 10.1182/bloodadvances.2018020040  0.315
2018 Sagiv-Barfi I, Czerwinski DK, Levy S, Alam IS, Mayer AT, Gambhir SS, Levy R. Eradication of spontaneous malignancy by local immunotherapy. Science Translational Medicine. 10. PMID 29386357 DOI: 10.1126/Scitranslmed.Aan4488  0.305
2016 Torchia J, Weiskopf K, Levy R. Targeting lymphoma with precision using semisynthetic anti-idiotype peptibodies. Proceedings of the National Academy of Sciences of the United States of America. 113: 5376-81. PMID 27114517 DOI: 10.1073/Pnas.1603335113  0.305
2015 Sagiv-Barfi I, Kohrt HE, Burckhardt L, Czerwinski DK, Levy R. Ibrutinib enhances the antitumor immune response induced by intratumoral injection of a TLR9 ligand in mouse lymphoma. Blood. 125: 2079-86. PMID 25662332 DOI: 10.1182/blood-2014-08-593137  0.33
2014 Kohrt HE, Colevas AD, Houot R, Weiskopf K, Goldstein MJ, Lund P, Mueller A, Sagiv-Barfi I, Marabelle A, Lira R, Troutner E, Richards L, Rajapaska A, Hebb J, Chester C, ... ... Levy R, et al. Targeting CD137 enhances the efficacy of cetuximab. The Journal of Clinical Investigation. 124: 2668-82. PMID 24837434 DOI: 10.1172/Jci73014  0.31
2014 Kohrt HE, Thielens A, Marabelle A, Sagiv-Barfi I, Sola C, Chanuc F, Fuseri N, Bonnafous C, Czerwinski D, Rajapaksa A, Waller E, Ugolini S, Vivier E, Romagné F, Levy R, et al. Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies. Blood. 123: 678-86. PMID 24326534 DOI: 10.1182/blood-2013-08-519199  0.306
2012 Sachen KL, Strohman MJ, Singletary J, Alizadeh AA, Kattah NH, Lossos C, Mellins ED, Levy S, Levy R. Self-antigen recognition by follicular lymphoma B-cell receptors. Blood. 120: 4182-90. PMID 23024238 DOI: 10.1182/blood-2012-05-427534  0.307
2012 Anderson MW, Zhao S, Freud AG, Czerwinski DK, Kohrt H, Alizadeh AA, Houot R, Azambuja D, Biasoli I, Morais JC, Spector N, Molina-Kirsch HF, Warnke RA, Levy R, Natkunam Y. CD137 is expressed in follicular dendritic cell tumors and in classical Hodgkin and T-cell lymphomas: diagnostic and therapeutic implications. The American Journal of Pathology. 181: 795-803. PMID 22901750 DOI: 10.1016/J.Ajpath.2012.05.015  0.34
2012 Ng PP, Jia M, Patel KG, Brody JD, Swartz JR, Levy S, Levy R. A vaccine directed to B cells and produced by cell-free protein synthesis generates potent antilymphoma immunity. Proceedings of the National Academy of Sciences of the United States of America. 109: 14526-31. PMID 22875703 DOI: 10.1073/Pnas.1211018109  0.352
2012 Kim YH, Gratzinger D, Harrison C, Brody JD, Czerwinski DK, Ai WZ, Morales A, Abdulla F, Xing L, Navi D, Tibshirani RJ, Advani RH, Lingala B, Shah S, Hoppe RT, ... Levy R, et al. In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: A phase 1/2 study Blood. 119: 355-363. PMID 22045986 DOI: 10.1182/Blood-2011-05-355222  0.332
2011 Houot R, Kohrt HE, Marabelle A, Levy R. Targeting immune effector cells to promote antibody-induced cytotoxicity in cancer immunotherapy. Trends in Immunology. 32: 510-6. PMID 21907000 DOI: 10.1016/j.it.2011.07.003  0.304
2011 Brody J, Kohrt H, Marabelle A, Levy R. Active and passive immunotherapy for lymphoma: proving principles and improving results. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 1864-75. PMID 21482977 DOI: 10.1200/JCO.2010.33.4623  0.35
2011 Kohrt HE, Houot R, Goldstein MJ, Weiskopf K, Alizadeh AA, Brody J, Müller A, Pachynski R, Czerwinski D, Coutre S, Chao MP, Chen L, Tedder TF, Levy R. CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies. Blood. 117: 2423-32. PMID 21193697 DOI: 10.1182/Blood-2010-08-301945  0.306
2011 Goldstein MJ, Varghese B, Brody JD, Rajapaksa R, Kohrt H, Czerwinski DK, Levy S, Levy R. A CpG-loaded tumor cell vaccine induces antitumor CD4+ T cells that are effective in adoptive therapy for large and established tumors. Blood. 117: 118-27. PMID 20876455 DOI: 10.1182/blood-2010-06-288456  0.344
2010 Irish JM, Myklebust JH, Alizadeh AA, Houot R, Sharman JP, Czerwinski DK, Nolan GP, Levy R. B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progression. Proceedings of the National Academy of Sciences of the United States of America. 107: 12747-54. PMID 20543139 DOI: 10.1073/Pnas.1002057107  0.316
2009 Houot R, Goldstein MJ, Kohrt HE, Myklebust JH, Alizadeh AA, Lin JT, Irish JM, Torchia JA, Kolstad A, Chen L, Levy R. Therapeutic effect of CD137 immunomodulation in lymphoma and its enhancement by Treg depletion. Blood. 114: 3431-8. PMID 19641184 DOI: 10.1182/Blood-2009-05-223958  0.315
2009 Ai WZ, Hou JZ, Zeiser R, Czerwinski D, Negrin RS, Levy R. Follicular lymphoma B cells induce the conversion of conventional CD4+ T cells to T-regulatory cells. International Journal of Cancer. 124: 239-44. PMID 18814264 DOI: 10.1002/ijc.23881  0.327
2009 Brody JD, Goldstein MJ, Czerwinski DK, Levy R. Immunotransplantation preferentially expands T-effector cells over T-regulatory cells and cures large lymphoma tumors. Blood. 113: 85-94. PMID 18812472 DOI: 10.1182/blood-2008-05-155457  0.319
2008 Houot R, Levy R. T-cell modulation combined with intratumoral CpG cures lymphoma in a mouse model without the need for chemotherapy. Blood. 113: 3546-52. PMID 18941113 DOI: 10.1182/blood-2008-07-170274  0.351
2007 Liu A, Guardino A, Chinsangaram L, Goldstein MJ, Panicali D, Levy R. Therapeutic vaccination against murine lymphoma by intratumoral injection of recombinant fowlpox virus encoding CD40 ligand. Cancer Research. 67: 7037-44. PMID 17638917 DOI: 10.1158/0008-5472.CAN-07-0224  0.332
2005 Song W, Levy R. Therapeutic vaccination against murine lymphoma by intratumoral injection of naive dendritic cells. Cancer Research. 65: 5958-64. PMID 15994975 DOI: 10.1158/0008-5472.CAN-05-0406  0.319
2004 Lambert SL, Okada CY, Levy R. TCR vaccines against a murine T cell lymphoma: a primary role for antibodies of the IgG2c class in tumor protection. Journal of Immunology (Baltimore, Md. : 1950). 172: 929-36. PMID 14707065 DOI: 10.4049/jimmunol.172.2.929  0.31
2002 Briones J, Timmerman J, Levy R. In vivo antitumor effect of CD40L-transduced tumor cells as a vaccine for B-cell lymphoma. Cancer Research. 62: 3195-9. PMID 12036933  0.355
2002 Timmerman JM, Czerwinski DK, Davis TA, Hsu FJ, Benike C, Hao ZM, Taidi B, Rajapaksa R, Caspar CB, Okada CY, van Beckhoven A, Liles TM, Engleman EG, Levy R. Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients. Blood. 99: 1517-26. PMID 11861263  0.318
Show low-probability matches.